As insurers have shifted more of the cost of medicines to the sickest patients, payment assistance from drug manufacturers has become a godsend for millions of Americans. But now, the Trump Administration has put that assistance, which comes in the form of popular co-pay coupons and cards, in serious jeopardy.
Read Full Article »
